Patent ID: 7709486
Filing Date: 2010-05-04
Classification: A61P,C04B,C07D

Abstract:
1. A compound selected from the group consisting of: 1-[2,6-Dimethoxypyrid-4-yl(methylene)]-1,4,8,11-tetraazacyclotetradecane (AMD 7032); 1-[2-Chloropyrid-4-yl(methylene)]-1,4,8,11-tetraazacyclotetradecane (AMD 7048); 1-[2,6-Dimethylpyrid-4-yl(methylene)]-1,4,8,11-tetraazacyclotetradecane (AMD 7060); 1-[2-Methylpyrid-4-yl(methylene)]-1,4,8,11-tetraazacyclotetradecane (AMD 7061); 1-[2,6-Dichloropyrid-4-yl(methylene)]-1,4,8,11-tetraazacyclotetradecane (AMD 3451); 1-[2-Chloropyrid-5-yl(methylene)]-1,4,8,11-tetraazacyclotetradecane (AMD 3454); N-[1,4,8,11-Tetraazacyclotetradecanyl-1,4-phenylenebis(methylene)]-purine (AMD 3472); 1-[1,4,8,11-Tetraazacyclotetradecanyl-1,4-phenylenebis(methylene)]-4-phenylpiperazine (AMD3526); and the pharmaceutically acceptable acid addition salts and metal complexes thereof.